Legend Biotech to present updated CARVYKTI long-term and real-world data at IMS meeting
Legend Biotech said data from CARTITUDE-2 and real-world evidence will be presented at the 23rd International Myeloma Society (IMS) Annual Meeting.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.